Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Queensland Health
Chinese Patent Office
Merck
Healthtrust
US Department of Justice
McKesson
McKinsey
UBS

Generated: May 26, 2018

DrugPatentWatch Database Preview

DARVON-N Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Summary for DARVON-N
US Patents:0
Applicants:2
NDAs:4
Bulk Api Vendors: 12
Formulation / Manufacturing:see details
DailyMed Link:DARVON-N at DailyMed
Drug patent expirations by year for DARVON-N
Synonyms for DARVON-N
(+)- Propoxyphene napsylate
[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate; naphthalene-2-sulfonic acid
[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate; naphthalene-2-sulfonic acid
17140-78-2
2-Butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate, 2-naphthalenesulfonate
2-Naphthalenesulfonic acid, compd. with (+)-alpha-(2-dimethylamino)-1-methylethyl-alpha-phenylphenethyl propionate (1:1)
2-Naphthalenesulfonic acid, compd. with (1S,2R)-3-(dimethylamino) -2-methyl-1-phenyl-1-(phenylmethyl)propyl propanoate (1:1)
2-Naphthalenesulfonic acid, compd. with (S-(R*,S*))-3-(dimethylamino)-2-methyl-1-phenyl-1-(phenylmethyl)p- ropyl propanoate (1:1)
2-NAPHTHALENESULFONIC ACID; PROPOXYPHENE
23239-43-2
5O7IW35N3C
AC-16040
AC1L1F41
AKOS015962225
AN-18686
API0009060
Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), (1S,2R)-, 2-naphthalenesulfonate (salt)
Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), (S-(R*,S*))-, 2-naphthalenesulfonate (salt)
C22H29NO2.C10H8O3S
CHEMBL1237085
D0HF0W
Darvon N
EINECS 241-205-7
Levopropoxyphene napsylate anhydrous
LEVOPROPOXYPHENE NAPSYLATE, ANHYDROUS
LS-94924
Naphthalene-2-sulphonic acid, compound with (S-(R*,S*))-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl propionate (1:1)
OR076289
Propoxyphene 2-naphthalenesulfonate
Propoxyphene napsylate
Propoxyphene napsylate (anhydrous)
Propoxyphene napsylate anhydrous
Propoxyphene-N
SCHEMBL9297768
UNII-5O7IW35N3C

US Patents and Regulatory Information for DARVON-N

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aaipharma Llc DARVON-N propoxyphene napsylate SUSPENSION;ORAL 016861-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aaipharma Llc DARVON-N W/ ASA aspirin; propoxyphene napsylate TABLET;ORAL 016863-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Xanodyne Pharm DARVON-N propoxyphene napsylate TABLET;ORAL 016862-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aaipharma Llc DARVON-N W/ ASA aspirin; propoxyphene napsylate CAPSULE;ORAL 016829-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Covington
Cantor Fitzgerald
McKinsey
UBS
Cerilliant
Fuji
Daiichi Sankyo
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.